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The effect of a Homoeopathic complex eye drop solution on dry eyes associated 
with computer-induced asthenopia 
1. Introduction 
Asthenopia (eyestrain) is defined as reversible fatigue of the eyes due to overuse of the visual 
system (Tiwari et al., 2011). This may be caused by an imbalance between visual capacity to fixate 
on a task and prolonged near work. Computer use is a common cause of asthenopia, with 
approximately 64-90% of people using computers suffering from ocular discomfort. The 
symptoms of asthenopia include tired, burning, itching eyes; lacrimation; photophobia; blurred 
and double vision; as well as occasional headaches (Blehm et al., 2005). Dryness of the eyes is 
also commonly associated with computer-induced asthenopia, and further aggravates asthenopic 
symptoms. Asthenopia has an impact on work productivity as well as quality of life (Djalilian, 
2016, Portello et al., 2012, Rosenfield, 2011). Conventional treatment for asthenopia includes the 
use of lubricating eye drops and occupational glasses (Gaby, 2008) and in addition forced blinking 
and punctal occlusion for dry eyes (Rosenfield, 2011). There are many homoeopathic remedies 
indicated for the treatment of asthenopia. The homoeopathic complex assessed in this study is a 
readily available eye drop solution that is indicated for the relief of computer-induced asthenopia. 
The complex contains the following remedies: Conium maculatum 6X, Natrium muriaticum 6X, 
Ruta graveolens 6X and Senega officinalis 6X. To date, no research could be found on the effect 
of the complex on dry eyes associated with computer-induced asthenopia. 
2. Aim of the study 
The aim of the study was to determine the effect of a homoeopathic complex eye drop solution on 
dry eyes associated with computer-induced asthenopia. A Visual Analogue Scale was used to rate 
eye discomfort and tear break-up time was measured with a Keratograph IV, which allowed for an 
objective measurement of dry eyes.  
3. Dry eyes 
Dry Eye Workshop (DEWS) (2007b) describes dry eyes as “a disorder of the tears and ocular 
surface caused by multiple factors”. Dryness of the eyes is due to either the insufficiency of or 
poor quality of tears to lubricate the eyes. It is typically caused by a decreased production of the 
aqueous fluid of the tears together with increased evaporation of the tears. An abnormality of any 
of the three layers of the tear film, namely the lipid, mucous, or the aqueous layers, produces an 
unstable tear film. Changes in the tear layer composition results in dry eyes, excessive lacrimation 
and other associated symptoms of ocular discomfort. Dry eyes are a common and chronic health 
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concern, affecting people worldwide (Reddy et al., 2004; Remeseiro et al., 2016). Dry eyes affect 
productivity at work and can increase absenteeism by 20% (Onwubiko et al., 2014) and 
optometrist visitations by 11-20% (Chan & Singh, 2015). 
Prolonged computer use results in dryness of the eyes due to a decreased blinking rate associated 
with computer use as well as a low concentration of Mucin5AC (a protective mucin) in tears (Chan 
& Singh, 2015; DEWS, 2007a) as a result of decreased production from the goblet cells (Uchino 
et al., 2014)  
4. Symptoms, signs and consequences of dry eyes  
The signs and symptoms of dry eyes are increased tear osmolarity, increased inflammatory 
mediators in the ocular surface, corneal friction, discomfort and damage, visual disturbance and 
tear film instability (DEWS, 2007b; DEWS, 2007c). Other characteristics include ocular surface 
staining, early tear break-up, pain, eye discomfort and increased corneal sensory excitability 
(Rosenfield, 2011, DEWS, 2007b).  
5. Classification of dry eyes  
There are two classes of dry eyes, namely the aqueous-deficient dry eye (ADDE) and the 
evaporative dry eye (EDE). The classification is based on cause and progression of ocular damage, 
leading to ocular disease as well as tear hyperosmolarity. ADDE and EDE both lead to the 
evaporation of the lacrimal fluid, however, from different causes (Asbell & Lemp, 2006). It has 
been demonstrated that VDU use is associated with both EDE and ADDE (figure 2.3) (Chan & 
Singh, 2015). 
6. Diagnosis and investigation  
The diagnosis of dry eyes is achieved through the use of any or a combination of the following 
procedures:  
 A symptom questionnaire assesses the severity of dry eye diseases symptoms (Bakkar et 
al., 2016; Chan & Singh, 2015; Chao et al., 2015). 
 Clinical history is essential for determining the aetiology of dry eyes (Asbell & Lemp, 
2006). 
 Tear film break-up time (TFBUT) evaluation with fluorescein monitors the treatment of 
dry eyes and essential for diagnosing severely dry eyes (Bron et al., 2014; Chan & Singh, 
2015). 
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 Non-invasive tear break-up time (TBUT) uses the Oculus Keratograph for assessing tear 
stability (Lan et al., 2014). 
 Schirmer 1 test assesses the tear volume, the severity of the dry eyes as well as the 
dysfunction of the aqueous layer (Bron et al., 2014).  
 Lid margin examination helps determines the severity and differentiates between the two 
types of dry eyes (Asbell & Lemp, 2006).  
 Meibomian gland expression forms part of the standard examination of dry eyes (Bron et 
al., 2014; Djalilian, 2015).  
 Other investigations include standard visual acuity, functional visual acuity as well as other 
new diagnostic measures such as Interferometry, Meibography and the Tearlab (Chan & 
Singh, 2015).  
6. METHODOLOGY 
 6.1 Research sample 
The research sample consisted of 50 participants, male and female, between the ages of 18-35 
years, recruited by means of purposive sampling. Advertisements were placed at the UJ Health 
Clinic, at the Doornfontein campus with relevant permission granted. 
Participants were included in the study if they: 
 Were male or female, between the ages of 18 and 35; and 
 Experienced at least two or more eye-related symptoms of asthenopia (blurred vision, frontal 
headache, dry eyes, photophobia, lacrimation, slow focusing, burning eye pain, itchy or 
irritated eyes, eye fatigue and diplopia) when using a Visual Display Unit (VDU) 
 Used a VDU for a minimum of 3 hours per day; and  
 Experienced eyestrain symptoms for at least one month prior to the study 
 
Participants were excluded from the study if they: 
 Wore contact lenses as these could comprise the tear layer and have an effect on the symptoms 
and results found; 
 Were suffering from frequent ocular infections or allergies, glaucoma, cataracts, styes or optic 
nerve atrophy;   
 Had been diagnosed with eye-related problems such as presbyopia, amblyopia, strabismus or 
uncorrected refractive error.  
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 Were currently using medications such as eye drops, anti-histamines, beta-blockers, diuretics, 
antidepressants, hormone replacement therapy, isotretinoin, anticholinergics or 
immunosuppressive drugs, as these would lead to disruption of the tear layer and ultimately 
dry eyes   
 Had underlying chronic conditions that may have resulted in dry eyes. These include: 
Rheumatoid arthritis, Systemic lupus erythematosus, hypothyroidism, omega 3 fatty acid 
deficiency, Vitamin A deficiency, Sjӧgren’s syndrome, scleroderma, connective tissue 
diseases, hepatitis C, undergoing radiation therapy or have had refractive surgery, epilepsy as 
well as other diagnosed neurological disorders; and/or  
 Had uncorrected refractive errors of 1.00D of hyperopia, 1.00D of myopia and 1.00D of 
astigmatism, as it may have added to the asthenopic symptoms.  
 
6.2 Research design and procedure  
This was a randomized, double-blind, placebo-controlled study, conducted over one day. The 
sample group was shared with another researcher, who was assessing the effect of the complex on 
the symptoms of computer-induced asthenopia using a Symptom Index Questionnaire. The 
participants attended an initial consultation at the UJ Optometry Clinic. All participants were 
requested to read the Information Form (Appendix B), sign the Participant Consent Form 
(Appendix C) once they agreed to participate, and complete the Participant Selection 
Questionnaire to assess if they met the inclusion and exclusion criteria (Appendix D). All 
participants who met the criteria were tested for any refractive errors by a qualified optometrist 
using an autorefractor, and due to the nature of the study, other visual anomalies such as 
accommodation and ocular motilities were not evaluated. If a participant had any significant 
uncorrected refractive errors they were referred to a qualified optometrist at the Optometry Clinic 
or elsewhere and were excluded from the study. After initial screening and selection to participate, 
the participants proceeded to the UJ computer lab to play a computer game for a two hour period. 
Participants wearing glasses for reading were required to wear their glasses while using the 
computer.  
 After the 2-hour period, all participants were requested to complete the Visual Analogue Scale 
(VAS) (Appendix G), and were assessed for Tear Break-Up Time (TBUT) using the Oculus 
Keratograph at the Optometry Clinic (Appendix E & F). Participants returned to the computer lab 
where they were randomly divided into two groups: one group received the homoeopathic complex 
eye drop solution (treatment group) and the other group received distilled water (placebo group). 
They were instructed to place two drops into each eye. Participants continued playing the game 
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for a period of 30 minutes, after which they completed the VAS questionnaire again. All 
participants returned to the Optometry Clinic to be assessed for the final TBUT. Measurements 
with the Keratograph were taken only in one eye as the researcher worked from the premise that 
the TBUT would be the same (or close to it) if the participants suffered from dry eyes.  
6.3 Medication administration 
The homoeopathic complex eye drop solution and distilled water were prepared and randomized 
by a registered laboratory using good manufacturing procedures, labeled and packaged in an 
identical manner in 10ml bottles. Each participant selected a number out of a hat and received the 
corresponding numbered bottle of medication 
 
6.4 Reliability and validity measures  
The TBUT using the Oculus Keratograph is a non-invasive test and is one of the standard clinical 
measures for assessing dry eyes. It has been used in similar previous research studies and proved 
to be a valid and reliable instrument to use (Lan et al., 2014).The measurements were performed 
by a qualified optometrist at the UJ Optometry clinic.  
The VAS is a numerical scale in which the participant is asked to subjectively rate the severity of 
ocular discomfort that they are experiencing (Bailey et al., 2012). The VAS is considered a valid 
and a reliable means of assessing subjective pain and discomfort (Hjermstad et al., 2011) and has 
been used in similar previous dry eye studies (Mohd et al., 2013).  
6.5 Data collection and analysis 
All data collected was analysed by means of descriptive and non-parametric tests, namely the 
Mann-Whitney, Shapiro-Wilk and Wilcoxon Signed Ranks tests (Kuhudzai, 2015) due to the small 
number of participants. The Mann Whitney test was used to statistically analyze and compare 
variables between two groups on a continuous scale. The Wilcoxon Signed-ranks test was used for 
repeated measures such as measurements done on two occasions. The Shapiro-Wilk test was used 
to test for normality. 
6.6 Interpretation of Findings  
All the remedies in the homoeopathic complex were in the 6X potency, which is considered a low 
potency (De Schepper, 2010). The outcomes of the study show a decreased severity of eye 
discomfort in both groups. There were significant changes noted on the TBUT reading on the 
placebo group. There were only two participants in the treatment group and five in the placebo 
group suffering from dry eyes prior to the study. While two hours of game playing was sufficient 
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to induce asthenopia, it was not long enough to induce dry eyes. Results showed that the treatment 
group did not outperform the placebo group, therefore the null hypothesis is supported. However, 
due to a small sample size, short duration of study and limited data it is difficult to make firm 
conclusions. No side effects were reported.  
The placebo used in this study consisted of distilled water, which while inert, also provided 
moisture to the eyes, lessening the associated desiccation accompanying reduced blinking with 
computer use. 
The inclusion criteria required that the participants had to have been using a computer for a 
minimum of three hours per day. It has been proven that dry eyes associated with VDU use 
increases proportionately with the amount of VDU use per day (Yokoi et al., 2015). Most 
participants in both groups were using computers for a period of 13 hours or more per week were 
therefore experiencing chronic asthenopia from prolonged computer use. It can be suggested that 
this factor could have negatively affected the outcomes of the study even though both groups were 
similar in distribution, an acute treatment of dry eyes (the homoeopathic preparation) was used to 
treat a chronic condition. The study should therefore have been conducted over a longer time period 
to determine the effect on chronic symptoms of dry eyes.  
Dry eyes is a condition mostly affecting the older population (DEWS, 2007a), although young 
people can also be affected, especially with the wide use of technology (Lan et al., 2014). This 
study was aimed at a younger population and the age range was limited to 18-35; the older 
population was not included so as to eliminate the possibility of refractive errors (especially 
presbyopia) and large age differences in the participants having an effect on the results. This age 
range may have negatively affected the study. 
Dry eyes affects mostly women, especially post menopause (DEWS, 2007b). The treatment group 
had more female participants and this may have contributed to the results seen as women tend to 
be more observant and aware of changes happening in their bodies than males (Weiss & 
Lonnquist, 2016).   
Other factors that might have caused positive results include: 
 Desire of the participants to please the researcher by positively complete the VAS 
questionnaire. 
 Moving from the computer laboratory to the Optometry clinic.  
  Additional time spent while waiting for the TBUT to be performed by the optometrist. 
 The research was conducted on a small sample size 
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 The treatment group had more females than the placebo 
 
7.  References 
Asbell, P.A. & Lemp, M.A. (2006). Dry eye disease. The clinician’s guide to diagnosis and 
treatment. Thieme Medical Publishers, Inc. p 3-195. 
Bakkar, M.M., Shihadeh, W.A., Haddad, M.F., Khader, Y.S. (2016). Epidemiology of symptoms 
of dry eye (DED) in Jordan: A cross-sectional non-clinical population-based study. Contact Lens 
and Anterior Eye. 39:197-202.  
Bailey, B., Gravel, J., Daoust, R. (2012). Reliability of the visual analog scale in children with 
acute pain in the emergency department. Pain.153 (4):839-842. 
Blehm, C., Vishnu, S., Khattak, A., Mitra, S., Yee, R.W. (2005). Computer Vision Syndrome. 
Survey of Ophthalmology. 50(3): 253-262. 
Bron, A.J., Tomlinson, A., Foulks, G.N., Pepose, J.S., Baudouin, C., Geerling, G., Nichols, K.K., 
Lemp, M.A. (2014). Rethinking dry eye. The Ocular Surface.12 (2S): S1-S31. 
Chan, E & Singh, A.D. (Editors).  (2015). The definition and classification of dry eye disease. 
Essentials of Ophthalmology, Dry Eye. A practical approach. New York & London:  Springer: 
Berlin Heidelberg. p 1-1063. 
Chao, W., Belmonte, Castillo Benitez Del J M. Bron, A.J., Dua, H.S., Nichols, K.K., Novack, 
G.D., Schrader, S., Willcox, M.D., Wolffsohn, J.S., Sullivan, D.A. (2015). Report of the inaugural 
meeting of the TFOS initiating innovation Series: Targeting the unmet need for the dry eye 
treatment. The Ocular Surface. 14(2):264-315. 
De Schepper, L. (2010). Hahnemman revisited: Hahnemannian textbook of classical homoeopathy 
for the professional. 4th impression. India: B Jain Publishers (P) Ltd. p 10-123. 
DEWS (Dry Eye WorkShop). (2007a). Diagnostic methodology subcommittee of the international 
dry eye workshop: report of the diagnostic methodology subcommittee of the international dry eye 
workshop. The Ocular Surface. 5(2):108-152. 
DEWS (Dry Eye WorkShop). (2007b).The definition and classification of dry eye disease: report 
of the definition and classification subcommittee of the international dry eye workshop. The 
Ocular Surface. 5(2):75-92.  
N. Mlambo & J. Pellow (2017)                                                                                                                8 
DEWS (Dry Eye WorkShop). (2007c). The Epidemiology of dry eye disease: report of the 
epidemiology subcommittee of the international dry eye workshop. Ocular Surface. 5(2):93-107.  
Djalilian, A. (Editor). (2015). Temperatures of the ocular surface, lid, and periorbital regions of 
Sjӧgren’s, evaporative, and aqueous-deficient dry eyes relative to n ormals. The Ocular Surface. 
14(1): 64-75. 
Djalilian, A. (Editor). (2016). Dietary supplementation with a combination of lactoferrin, fish oil, 
and enterococcus faecium WB2000 for treating dry eye: A rat model and human clinical study. 
The Ocular surface.14 (2): 255-263.  
Gaby, A.R. (2008). Nutritional therapies for ocular disorders: Part 3. Alternative Medicine Review. 
13(3): 191-204.  
Hjermstad, M.J., Fayers, P.M., Haugen, D.F., Caraceni, A., Hanks, G.W., Loge, J.H., Fainsinger, 
R., Aass, N., Kaasa, S. (2011). Studies comparing numerical rating scales, verbal rating scales and 
visual analogue scales for assessment of pain of intensity in adults: a systematic literature review. 
Journal of Pain & Symptom Management.  41(6): 1073-1093. 
 
Kuhudzai, A. (2015). Statkon. Personal discussion. 11 March 2015, 20 Chiselhurst Avenue 
Aukland Park. (akuhudzai@uj.ac.za).  
Lan, W., Lin, L., Yang, X., Yu, M. (2014). Automatic non-invasive Tear Breakup Time (TBUT) 
and Convectional Fluorescent TBUT. Optometry and Vision Science. 12:1-7. 
Mohammadpour, M., Mehrabi, S., Hasanpoor, N., Mirshahi, R. (2016). Effects of adjuvant omega- 
3 fatty supplementation on dry eye syndrome following cataract surgery: A randomized clinical 
trial. Journal of Current Ophthalmology: 1-6.  
Mohd, B., Nguan D., Bashirah, I., Chan, K. (2013). Tear proteomics in young Malays with dry 
eyes. Optometry and vision science program, Faculty of Health Science, University Kebangsaan, 
Malaysia, 12(2). 
Onwubiko S.N., Eze B.I., Udeh N.N., Arinze O.C., Onwasigwe E.N., Umeh R.E. (2014). Dry eye 
disease: prevalence, distribution and determinants in a hospital-based population. Contact lens 
Anterior Eye 37(3):157-161. 
Portello, J.K, Rosenfield M, Bababekova Y, Estrada JM, Leon A. (2012). Computer–related visual 
symptoms in office workers. Ophthalmic & Physiological Optics. 32(5):375-382. 
N. Mlambo & J. Pellow (2017)                                                                                                                9 
Reddy P., Grad O., Rajagopalan K. (2004). The economic burden of dry eye: a conceptual 
framework and preliminary assessment. Cornea. 23(8):751-761.  
Remeseiro, B., Barreira, N., Resua, C.G., Lira, M., Giraldez. M, J., Pimentel, E.Y., Penedo, M. G 
(2016). iDEAS: A web-based system for dry eye assessment. Computer Methods and Programs 
in Biomedicine.130: 186-197.  
Rosenfield, M. (2011). Computer vision syndrome: a review of ocular causes and potential 
treatments. Ophthalmic & Physiologic Optics. 31: 502-515. 
Schaumberg, D.A., Dana. R., Buring, J.E., Sullivan, D.A. (2009). Prevalence of dry eye disease 
among US men: estimates. Archives of Ophthalmology. 127(6):763-768. 
Tiwari, R., Saha, A., Parikh, R. (2011). Asthenopia (eyestrain) in working children in gem-
polishing industries. Journal of Toxicology and Industrial Health. 27(3):243-247. 
Tortora, G.J. (2011). Principles of anatomy & physiology.  13th edition. Hobolen, NJ: Wiley. p 
466-476. 
Uchino, Y., Uchino, M., Yokoi, N., Dogru, M., Kawashima, M., Okada, N., Inaba, T., Tamaki, S., 
Komuro, A., Sonomura, Y., Kato, H., Argüeso, P., Kinoshita, S., Tsubota, K. (2014). Alteration 
of tear mucin 5AC in office workers using visual display terminals. JAMA Ophthalmology, 
132(8):985-992. 
Weiss, G.L. & Lonnquist, L. E. (2016). The sociology of health, healing and illness. 8th edition. 
London & New York: Routledge.Taylor & Francis Group. p 10-400.  
Yokoi, N., Uchino, M., Uchino, Y., Dogru, M., Kawashima, M., Komuro, A., Sonomura, Y., Kato, 
H., Tsubota, K., Kinoshita, S. (2015). Importance of Tear Film Instability in Dry Eye Disease in 
Office Workers Using Visual Display Terminals: The Osaka Study. American Journal of 
Ophthalmology. 159:4.  
 
 
